In NSCLC cells, overexpression of RBM4 was found to neutralize SRSF1 to inhibit mTOR activation and induce apoptosis by shifting BCL-X splicing to favor the pro-apoptotic BCL-Xs isoform [32]. The gene discussed is SRSF1; the disease is non-small cell lung carcinoma.